Jean-Philippe Vial

9PUBLICATIONS
31CO-AUTHORS
HaematologyImmunogenetics (incl. genetic immunology)Regenerative medicine (incl. stem cells)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 31, 2024
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.

Camille Gondran, Pierre-Yves Dumas, Emilie Bérard

|Feb 26, 2024
Prognostic value of postinduction medullary myeloid recovery by flow cytometry in acute myeloid leukemia.

Céline Row, Nicolas Lechevalier, Jean Philippe Vial

|Nov 01, 2022
Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia.

Alban Canali, Inès Vergnolle, Sarah Bertoli

|Aug 16, 2022
Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia.

François Vergez, Laetitia Largeaud, Sarah Bertoli

|Sep 27, 2021
CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome.

Inès Vergnolle, Claudia Douat-Beyries, Serge Boulinguez

Pageof 2